Cargando…
The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
BACKGROUND: The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection against genital warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any effects on the prevention of GW reported in randomised controlled clinical trials (RCTs) and ti...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254696/ https://www.ncbi.nlm.nih.gov/pubmed/32460747 http://dx.doi.org/10.1186/s12889-020-08753-y |
_version_ | 1783539590686048256 |
---|---|
author | Lukács, Anita Máté, Zsuzsanna Farkas, Nelli Mikó, Alexandra Tenk, Judit Hegyi, Péter Németh, Balázs Czumbel, László Márk Wuttapon, Sadaeng Kiss, István Gyöngyi, Zoltán Varga, Gábor Rumbus, Zoltán Szabó, Andrea |
author_facet | Lukács, Anita Máté, Zsuzsanna Farkas, Nelli Mikó, Alexandra Tenk, Judit Hegyi, Péter Németh, Balázs Czumbel, László Márk Wuttapon, Sadaeng Kiss, István Gyöngyi, Zoltán Varga, Gábor Rumbus, Zoltán Szabó, Andrea |
author_sort | Lukács, Anita |
collection | PubMed |
description | BACKGROUND: The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection against genital warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any effects on the prevention of GW reported in randomised controlled clinical trials (RCTs) and time-trend analyses. METHODS: This meta-analysis was performed according to the PRISMA guidelines using the PICO format. We searched in three electronic databases (PubMed, Embase, Cochrane Trials), and assessed heterogeneity using the Q-test and I-squared statistics, meta-regression was also performed. Odds ratios (OR) and their confidence intervals (CI) were calculated. The sensitivity was tested by leave-one-out method. We evaluated the presence of publication bias using the funnel plot graph and the Copas selection model. The strength of evidence was assessed using the GRADE approach. RESULTS: Eight RCTs (per-protocol populations) and eight time-trend ecological studies were included in this meta-analysis. A significant reduction (pooled OR = 0.03, 95% CI: 0.01–0.09; I-squared = 53.6%) of GW in young women was recorded in RCTs, and in time-trend analyses both in young women (pooled OR = 0.36, CI 95% = 0.26–0.51; I-squared = 98.2%), and in young men (pooled OR = 0.69, 95% CI = 0.61–0.78; I-squared = 92.7%). In subgroup analysis, a significant reduction of the number of GW events was observed especially in women under 21 years (pooled OR = 0.33, 95% CI = 0.17–0.63). Leave-one-out analysis showed that similar results could be obtained after excluding one study, meta-regression did not show significant difference. CONCLUSIONS: Prophylactic, quadrivalent HPV vaccination can prevent GW in healthy women and men, therefore, it should be included in routine immunization programme. |
format | Online Article Text |
id | pubmed-7254696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72546962020-06-07 The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis Lukács, Anita Máté, Zsuzsanna Farkas, Nelli Mikó, Alexandra Tenk, Judit Hegyi, Péter Németh, Balázs Czumbel, László Márk Wuttapon, Sadaeng Kiss, István Gyöngyi, Zoltán Varga, Gábor Rumbus, Zoltán Szabó, Andrea BMC Public Health Research Article BACKGROUND: The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection against genital warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any effects on the prevention of GW reported in randomised controlled clinical trials (RCTs) and time-trend analyses. METHODS: This meta-analysis was performed according to the PRISMA guidelines using the PICO format. We searched in three electronic databases (PubMed, Embase, Cochrane Trials), and assessed heterogeneity using the Q-test and I-squared statistics, meta-regression was also performed. Odds ratios (OR) and their confidence intervals (CI) were calculated. The sensitivity was tested by leave-one-out method. We evaluated the presence of publication bias using the funnel plot graph and the Copas selection model. The strength of evidence was assessed using the GRADE approach. RESULTS: Eight RCTs (per-protocol populations) and eight time-trend ecological studies were included in this meta-analysis. A significant reduction (pooled OR = 0.03, 95% CI: 0.01–0.09; I-squared = 53.6%) of GW in young women was recorded in RCTs, and in time-trend analyses both in young women (pooled OR = 0.36, CI 95% = 0.26–0.51; I-squared = 98.2%), and in young men (pooled OR = 0.69, 95% CI = 0.61–0.78; I-squared = 92.7%). In subgroup analysis, a significant reduction of the number of GW events was observed especially in women under 21 years (pooled OR = 0.33, 95% CI = 0.17–0.63). Leave-one-out analysis showed that similar results could be obtained after excluding one study, meta-regression did not show significant difference. CONCLUSIONS: Prophylactic, quadrivalent HPV vaccination can prevent GW in healthy women and men, therefore, it should be included in routine immunization programme. BioMed Central 2020-05-28 /pmc/articles/PMC7254696/ /pubmed/32460747 http://dx.doi.org/10.1186/s12889-020-08753-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Lukács, Anita Máté, Zsuzsanna Farkas, Nelli Mikó, Alexandra Tenk, Judit Hegyi, Péter Németh, Balázs Czumbel, László Márk Wuttapon, Sadaeng Kiss, István Gyöngyi, Zoltán Varga, Gábor Rumbus, Zoltán Szabó, Andrea The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis |
title | The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis |
title_full | The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis |
title_fullStr | The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis |
title_full_unstemmed | The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis |
title_short | The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis |
title_sort | quadrivalent hpv vaccine is protective against genital warts: a meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254696/ https://www.ncbi.nlm.nih.gov/pubmed/32460747 http://dx.doi.org/10.1186/s12889-020-08753-y |
work_keys_str_mv | AT lukacsanita thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT matezsuzsanna thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT farkasnelli thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT mikoalexandra thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT tenkjudit thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT hegyipeter thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT nemethbalazs thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT czumbellaszlomark thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT wuttaponsadaeng thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT kissistvan thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT gyongyizoltan thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT vargagabor thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT rumbuszoltan thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT szaboandrea thequadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT lukacsanita quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT matezsuzsanna quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT farkasnelli quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT mikoalexandra quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT tenkjudit quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT hegyipeter quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT nemethbalazs quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT czumbellaszlomark quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT wuttaponsadaeng quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT kissistvan quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT gyongyizoltan quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT vargagabor quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT rumbuszoltan quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis AT szaboandrea quadrivalenthpvvaccineisprotectiveagainstgenitalwartsametaanalysis |